Possible allergic reactions to cyclopentolate hydrochloride: case reports with literature review of uses and adverse reactions
- PMID: 2034449
Possible allergic reactions to cyclopentolate hydrochloride: case reports with literature review of uses and adverse reactions
Abstract
Cyclopentolate has been widely used as a cycloplegic and mydriatic agent for over 30 years. It has gained widespread use as the cycloplegic drug of first choice for most children over the age of 1 year and allows many optometrists and ophthalmologists to carry out quick, successful cycloplegic refractions with few complications. During this time very few side-effects have been reported with the most commonly used 1% solution. This paper outlines two cases in which a possible allergic-type reaction occurred shortly after the instillation of 1% cyclopentolate hydrochloride in 'Minims' form (Smith and Nephew). This article also reviews the uses and side-effects of cyclopentolate and aims to warn practitioners about the possibility of such reactions, ways of avoiding their occurrence and suitable measures to take should they occur.
Similar articles
-
Dilation efficacy: is 1% cyclopentolate enough?Optometry. 2007 Mar;78(3):119-21. doi: 10.1016/j.optm.2006.06.018. Optometry. 2007. PMID: 17321460
-
Anaphylactic reaction due to cyclopentolate in a 4-year-old child.J Investig Allergol Clin Immunol. 2010;20(4):347-8. J Investig Allergol Clin Immunol. 2010. PMID: 20815313
-
Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients.J Cataract Refract Surg. 2005 Apr;31(4):694-700. doi: 10.1016/j.jcrs.2004.10.068. J Cataract Refract Surg. 2005. PMID: 15899444 Clinical Trial.
-
Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: case report and review of the literature.J Cataract Refract Surg. 2003 May;29(5):1026-30. doi: 10.1016/s0886-3350(02)01651-6. J Cataract Refract Surg. 2003. PMID: 12781295 Review.
-
Mydriatic and cycloplegic drugs: a review of ocular and systemic complications.Am J Optom Physiol Opt. 1982 Feb;59(2):162-77. Am J Optom Physiol Opt. 1982. PMID: 7039329 Review.
Cited by
-
IMI-Instrumentation for Myopia Management.Invest Ophthalmol Vis Sci. 2025 Jul 1;66(9):7. doi: 10.1167/iovs.66.9.7. Invest Ophthalmol Vis Sci. 2025. PMID: 40600762 Free PMC article. Review.
-
Influence of power and the time of application of fogging lenses on accommodation.Biomed Opt Express. 2023 Sep 27;14(10):5488-5498. doi: 10.1364/BOE.486442. eCollection 2023 Oct 1. Biomed Opt Express. 2023. PMID: 37854562 Free PMC article.
-
A metric-based image-formation model explains the improvement in subjective refraction using temporal defocus waves.Optom Vis Sci. 2025 Apr 1;102(4):196-203. doi: 10.1097/OPX.0000000000002239. Epub 2025 Feb 25. Optom Vis Sci. 2025. PMID: 39999358 Free PMC article.
-
Response to Banerjee et al.Eye (Lond). 2013 May;27(5):677. doi: 10.1038/eye.2013.30. Epub 2013 Mar 1. Eye (Lond). 2013. PMID: 23449507 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical